Can frailty predict cancer recovery? new study aims to find out

NCT ID NCT06089083

Recruiting now Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 500 adults with newly diagnosed gynecologic cancer to understand how frailty—a state of increased vulnerability—impacts their recovery and quality of life. Researchers will assess physical function, collect questionnaires, and review surgical outcomes. The goal is to identify risk factors and improve care for frail patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify frail patients earlier and tailor care to improve their recovery and quality of life.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, so it cannot lead to a cure or symptom relief on its own.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer female reproductive system neoplasm Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GYNECOLOGIC CANCER GYNECOLOGIC NEOPLASM MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM

Contacts and locations

Show contact details

Locations

Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
University of California, San Francisco
RECRUITING

San Francisco, California, 94143, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.